HK Stock Market Move | 3SBIO (01530) rose over 7% with an adjusted net profit attributable to shareholders growing 26.5% year-on-year in the first half of the year.

3SBIO (01530) has risen over 7%, and as of the time of writing, it is up 6.85%, priced at HKD 17.63, with a transaction volume of HKD 395 million. In terms of news, 3SBIO released its mid-term performance report for 2026. In the first half of the year, the company achieved an operating income of 4.53 billion yuan, a year-on-year increase of 3.9%; net profit attributable to shareholders was 1.15 billion yuan, a decrease of 15.58% year-on-year; adjusted net profit attributable to shareholders was 1.44 billion yuan, a year-on-year increase of 26.5%. In the first half of the year, core products received marketing approval in 23 countries globally, and overseas product sales increased by 43% year-on-year, driven by market penetration of the company's rhEPO, YisaiPu, rhTPO, and other products in several emerging economies. The group expects that foreseeable fluctuations in the RMB exchange rate will not have a significant adverse impact on operations.